Contents

Current Molecular Medicine, Volume 13 - Number 5

Editorial (Hot Topic:Human Pluripotent Stem Cells in Regenerative and Personalized Medicine)

, 13(5): 691 - 694

Thomas Dittmar and Michael Rossbach


DOI: 10.2174/1566524011313050001




Pluripotency-Regulating Networks Provide Basis for Reprogramming

, 13(5): 695 - 706

I. Aksoy and L.W. Stanton


DOI: 10.2174/1566524011313050002




Pluripotent Stem Cell-Derived Somatic Stem Cells as Tool to Study the Role of MicroRNAs in Early Human Neural Development

, 13(5): 707 - 722

B. Roese- Koerner, L. Stappert, P. Koch, O. Brustle and L. Borghese


DOI: 10.2174/1566524011313050003




Human Progenitor Cells for Bone Engineering Applications

, 13(5): 723 - 734

G.M. de Peppo, P. Thomsen, C. Karlsson, R. Strehl, A. Lindahl and J. Hyllner


DOI: 10.2174/1566524011313050004




The Dark Side of Stem Cells: Triggering Cancer Progression by Cell Fusion

, 13(5): 735 - 750

T. Dittmar, C. Nagler, B. Niggemann and K.S. Zanker


DOI: 10.2174/1566524011313050005




MicroRNAs and Cancer: Towards a Personalized Medicine

, 13(5): 751 - 756

M. Fabbri


DOI: 10.2174/1566524011313050006




MicroRNA Regulation and Role in Stem Cell Maintenance, Cardiac Differentiation and Hypertrophy

, 13(5): 757 - 764

K.T. Kuppusamy, H. Sperber and H. Ruohola- Baker


DOI: 10.2174/1566524011313050007




Improved Generation of Patient-Specific Induced Pluripotent Stem Cells Using a Chemically-Defined and Matrigel-Based Approach

, 13(5): 765 - 776

B. Groß, M. Sgodda, M. Rasche, A. Schambach, G. Gohring, B. Schlegelberger, B. Greber, T. Linden, D. Reinhardt, T. Cantz and J.-H. Klusmann


DOI: 10.2174/1566524011313050008




Differences Between Parkinson’s and Huntington’s Diseases and Their Role for Prioritization of Stem Cell-Based Treatments

, 13(5): 777 - 791

K. Hug and G. Hermeren


DOI: 10.2174/1566524011313050009




Induced Pluripotent Stem Cells (iPSCs) Derived from Different Cell Sources and their Potential for Regenerative and Personalized Medicine

, 13(5): 792 - 805

R. Shtrichman, I. Germanguz and J. Itskovitz- Eldor


DOI: 10.2174/1566524011313050010




What Makes a Pluripotency Reprogramming Factor?

, 13(5): 806 - 814

R. Jauch and P.R. Kolatkar


DOI: 10.2174/1566524011313050011




Development of Patient-Specific Hematopoietic Stem and Progenitor Cell Grafts from Pluripotent Stem Cells, In Vitro

, 13(5): 815 - 820

H. Klump, N. Teichweyde, C. Meyer and P.A. Horn


DOI: 10.2174/1566524011313050012




The Multiple Aspects of Stroke and Stem Cell Therapy

, 13(5): 821 - 831

B. Onteniente


DOI: 10.2174/1566524011313050013




Disease-Specific iPS Cell Models in Neuroscience

, 13(5): 832 - 841

M. Peitz, J. Jungverdorben and O. Brustle


DOI: 10.2174/1566524011313050014




Improved Hepatic Differentiation Strategies for Human Induced Pluripotent Stem Cells

, 13(5): 842 - 855

M. Sgodda, S. Mobus, J. Hoepfner, A.D. Sharma, A. Schambach, B. Greber, M. Ott and T. Cantz


DOI: 10.2174/1566524011313050015




Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation

, 13(5): 856 - 867

J. Stagg and J. Galipeau


DOI: 10.2174/1566524011313050016




Roadmap to Cellular Reprogramming – Manipulating Transcriptional Networks with DNA, RNA, Proteins and Small Molecules

, 13(5): 868 - 878

P. Worsdorfer, M. Thier, A. Kadari and F. Edenhofer


DOI: 10.2174/1566524011313050017




A Comment on Pluripotent Stem Cells in Next-Generation Biomedical Theranostics

, 13(5): 879 - 883

M. Rossbach


DOI: 10.2174/1566524011313050018




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science